Early markers of cardiovascular disease are associated with occupational exposure to polycyclic aromatic hydrocarbons

Ayman Alhamdow, Christian Lindh, Maria Albin, Per Gustavsson, Håkan Tinnerberg, Karin Broberg, Ayman Alhamdow, Christian Lindh, Maria Albin, Per Gustavsson, Håkan Tinnerberg, Karin Broberg

Abstract

Occupational exposure to soot, rich in polycyclic aromatic hydrocarbons (PAH), has been associated with increased risk of cardiovascular disease (CVD). However, our knowledge about PAH exposure and early markers of CVD remains limited. In this cross-sectional study of 151 chimney sweeps and 152 controls, we investigated occupational exposure to PAH and early markers of CVD. Blood pressure (BP) (chimney sweeps only), urinary PAH metabolites and serum biomarkers were measured (C-reactive protein, homocysteine, gamma-glutamyltransferase, cholesterol, HDL, LDL, and triglycerides). Chimney sweeps had up to 7 times higher concentrations of PAH metabolites in urine than controls (P < 0.001): median concentrations (adjusted for specific gravity) for 1-hydroxypyrene, 2-hydroxyphenanthrene, 3-hydroxybenzo[a]pyrene, and 3-hydroxybenzo[a]anthracene were 0.56 µg/L, 0.78 µg/L, 4.75 ng/L, and 6.28 ng/L, respectively. Compared with controls, chimney sweeps had increased homocysteine, cholesterol, and HDL (β = 3.4 µmol/L, 0.43 mmol/L, and 0.13 mmol/L, respectively, P ≤ 0.003, adjusted for age, BMI, and smoking). In chimney sweeps, PAH metabolites correlated positively with the percentage of soot sweeping (P < 0.001). 2-hydroxyphenanthrene, 3-hydroxybenzo[a]pyrene, and 3-hydroxybenzo[a]anthracene were positively associated with diastolic BP (P < 0.044, adjusted for age, BMI, and smoking). PAH exposure among chimney sweeps resulted in elevated levels of markers for CVD risk. These findings stress the need to reduce occupational exposure to PAH.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Trends for work tasks, use of fuel by clients, and use of masks in chimney sweeps. (a) Fraction of work (%) for different work tasks from 1963 to 2013. (b) Fraction of work (%) with different types of fuels used by clients from 1975 to 2013. (c) Percentage of chimney sweeps that used masks (simple and/or advanced) during work for five different work tasks. *Wilcoxson signed rank test for work tasks before/after the year 2002. **Soot sweeping.
Figure 2
Figure 2
Differences in PAH metabolites between chimney sweeps (exposed group) that spent less than 50% (low soot sweeping) and those who spent 50% or more (high soot sweeping) of their working time doing total soot sweeping (private homes and industry in the past 12 months). (a) PAH metabolites 1-hydroxypyrene (1-OH-PYR) and 2-hydroxyphenanthrene (2-OH-PH). (b) PAH metabolites 3-hydroxybenzo[a]pyrene (3-OH-BaP) and 3-hydroxybenzo[a]anthracene (3-OH-BaA). Standard errors for PAH metabolites are represented by whiskers on top of each bar. *P-value for general linear model adjusted for age, BMI and smoking status.

References

    1. Samanta SK, Singh OV, Jain RK. Polycyclic aromatic hydrocarbons: environmental pollution and bioremediation. Trends Biotechnol. 2002;20:243–248. doi: 10.1016/S0167-7799(02)01943-1.
    1. Moorthy B, Chu C, Carlin DJ. Polycyclic aromatic hydrocarbons: from metabolism to lung cancer. Toxicol. Sci. 2015;145:5–15. doi: 10.1093/toxsci/kfv040.
    1. Burstyn I, et al. Polycyclic aromatic hydrocarbons and fatal ischemic heart disease. Epidemiology. 2005;16:744–750. doi: 10.1097/01.ede.0000181310.65043.2f.
    1. Xu X, Hu H, Kearney GD, Kan H, Sheps DS. Studying the effects of polycyclic aromatic hydrocarbons on peripheral arterial disease in the United States. Sci. Total Environ. 2013;461–462:341–347. doi: 10.1016/j.scitotenv.2013.04.089.
    1. Xu X, et al. Studying associations between urinary metabolites of polycyclic aromatic hydrocarbons (PAHs) and cardiovascular diseases in the United States. Sci. Total Environ. 2010;408:4943–4948. doi: 10.1016/j.scitotenv.2010.07.034.
    1. Gustavsson P, et al. A population-based case-referent study of myocardial infarction and occupational exposure to motor exhaust, other combustion products, organic solvents, lead, and dynamite. Stockholm Heart Epidemiology Program (SHEEP) Study Group. Epidemiology. 2001;12:222–228. doi: 10.1097/00001648-200103000-00015.
    1. Friesen MC, et al. Chronic and acute effects of coal tar pitch exposure and cardiopulmonary mortality among aluminum smelter workers. Am. J. Epidemiol. 2010;172:790–799. doi: 10.1093/aje/kwq208.
    1. Jeng HA, et al. Polycyclic aromatic hydrocarbon-induced oxidative stress and lipid peroxidation in relation to immunological alteration. Occup. Environ. Med. 2011;68:653–658. doi: 10.1136/oem.2010.055020.
    1. Curfs DM, et al. Polycyclic aromatic hydrocarbons induce an inflammatory atherosclerotic plaque phenotype irrespective of their DNA binding properties. FASEB J. 2005;19:1290–1292.
    1. IARC (International Agency for Research on Cancer).ss Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 92 (2010).
    1. Kauppinen T, et al. Occupational exposure to carcinogens in the European Union. Occup. Environ. Med. 2000;57:10–18. doi: 10.1136/oem.57.1.10.
    1. Letzel S, et al. Study on the internal exposure of chimney sweeps to hazardous substances. Occupational hygiene. 1999;5:59–71.
    1. Knecht U, Bolm-Audorff U, Woitowitz HJ. Atmospheric concentrations of polycyclic aromatic hydrocarbons during chimney sweeping. Br. J. Ind. Med. 1989;46:479–482.
    1. Andersson K. Skorstensfejares exponering för damm, PAH, metaller, och asbest (Chimney sweeps’ exposure to dust, PAH, metals, and asbestos) [in Swedish]. Swedish Environmental Research Institute, Gothenburg, Sweden (1987).
    1. Fehrmann, R. Traek af skorstensfejernes arbejdsmiljo (chimney sweeps’ occupational environment) [in Danish]. Danish Work Environment Fund, Copenhagen, Denmark (1982).
    1. Hogstedt C, Jansson C, Hugosson M, Tinnerberg H, Gustavsson P. Cancer incidence in a cohort of Swedish chimney sweeps, 1958-2006. Am J Public Health. 2013;103:1708–1714. doi: 10.2105/AJPH.2012.300860.
    1. Pukkala E, et al. Occupation and cancer - follow-up of 15 million people in five Nordic countries. Acta Oncol. 2009;48:646–790. doi: 10.1080/02841860902913546.
    1. Haldorsen T, Andersen A, Boffetta P. Smoking-adjusted incidence of lung cancer by occupation among Norwegian men. Cancer Causes Control. 2004;15:139–147. doi: 10.1023/B:CACO.0000019485.74818.d6.
    1. Evanoff BA, Gustavsson P, Hogstedt C. Mortality and incidence of cancer in a cohort of Swedish chimney sweeps: an extended follow up study. Br. J. Ind. Med. 1993;50:450–459.
    1. Gustavsson P, Jansson C, Hogstedt C. Incidence of myocardial infarction in Swedish chimney sweeps 1991–2005: a prospective cohort study. Occup. Environ. Med. 2013;70:505–507. doi: 10.1136/oemed-2013-101371.
    1. Jansson C, Alderling M, Hogstedt C, Gustavsson P. Mortality among Swedish chimney sweeps (1952–2006): an extended cohort study. Occup. Environ. Med. 2012;69:41–47. doi: 10.1136/oem.2010.064246.
    1. Alhamdow A, et al. Chimney sweeps in Sweden: a questionnaire-based assessment of long-term changes in work conditions, and current eye and airway symptoms. Int Arch Occup Environ Health. 2017;90:207–216. doi: 10.1007/s00420-016-1186-7.
    1. Barbeau D, Maitre A, Marques M. Highly sensitive routine method for urinary 3-hydroxybenzo a pyrene quantitation using liquid chromatography-fluorescence detection and automated off-line solid phase extraction. Analyst. 2011;136:1183–1191. doi: 10.1039/c0an00428f.
    1. Marie C, Bouchard M, Heredia-Ortiz R, Viau C, Maitre A. A toxicokinetic study to elucidate 3-hydroxybenzo(a)pyrene atypical urinary excretion profile following intravenous injection of benzo(a)pyrene in rats. J. Appl. Toxicol. 2010;30:402–410.
    1. Bouchard M, Viau C. Urinary excretion kinetics of pyrene and benzo(a)pyrene metabolites following intravenous administration of the parent compounds or the metabolites. Toxicol. Appl. Pharmacol. 1996;139:301–309. doi: 10.1006/taap.1996.0169.
    1. CDC (Centers for Disease Control and Prevention). 2010. Publications and reports of the surgeon general. (How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general). Atlanta, GA. Available from [accessed 26 January 2017] (2010).
    1. IARC (International Agency for Research on Cancer). Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 83 (2004).
    1. Choi H, Zdeb M, Perera F, Spengler J. Estimation of chronic personal exposure to airborne polycyclic aromatic hydrocarbons. Sci. Total. Environ. 2015;15:252–261. doi: 10.1016/j.scitotenv.2015.04.085.
    1. Brook RD, et al. Particulate matter air pollution and cardiovascular disease. Circulation. 2010;121:2331–2378. doi: 10.1161/CIR.0b013e3181dbece1.
    1. IARC (International Agency for Research on Cancer). Soot, as found in occupational exposure of chimney sweeps. IARC Monographs on the evaluation of carcinogenic risks to humans. Volume 100F (2012).
    1. Pavanello S, Genova A, Foa V, Clonfero E. Assessment of occupational exposure to aromatic polycyclic hydrocarbons determining urinary levels of 1-pyrenol. Med. Lav. 2000;91:192–205.
    1. Goen T, Gundel J, Schaller KH, Angerer J. The elimination of 1-hydroxypyrene in the urine of the general population and workers with different occupational exposures to PAH. Sci. Total Environ. 1995;163:195–201. doi: 10.1016/0048-9697(95)04484-I.
    1. Strickland P, Kang D, Sithisarankul P. Polycyclic aromatic hydrocarbon metabolites in urine as biomarkers of exposure and effect. Environ. Health Perspect. 1996;104(Suppl 5):927–932. doi: 10.1289/ehp.96104s5927.
    1. Forster K, et al. 3-Hydroxybenzo[a]pyrene in the urine of workers with occupational exposure to polycyclic aromatic hydrocarbons in different industries. Occup. Environ. Med. 2008;65:224–229. doi: 10.1136/oem.2006.030809.
    1. Yamano Y, et al. Urinary 1-hydroxypyrene as a comprehensive carcinogenic biomarker of exposure to polycyclic aromatic hydrocarbons: a cross-sectional study of coke oven workers in China. Int. Arch. Occup. Environ. Health. 2014;87:705–713. doi: 10.1007/s00420-013-0913-6.
    1. Gündel J, Schaller KH, Angerer J. Occupational exposure to polycyclic aromatic hydrocarbons in a fireproof stone producing plant: biological monitoring of 1-hydroxypyrene, 1-, 2-, 3- and 4-hydroxyphenanthrene, 4-hydroxybenz(a)anthracene and 3-hydroxybenzo(a)pyrene. Int. Arch. Occup. Environ. Health. 2000;73:270–274. doi: 10.1007/s004200050427.
    1. Li Z, et al. Excretion profiles and half-lives of ten urinary polycyclic aromatic hydrocarbon metabolites after dietary exposure. Chem. Res. Toxicol. 2012;25:1452–1461. doi: 10.1021/tx300108e.
    1. Brzeznicki S, Jakubowski M, Czerski B. Elimination of 1-hydroxypyrene after human volunteer exposure to polycyclic aromatic hydrocarbons. Int. Arch. Occup. Environ. Health. 1997;70:257–260. doi: 10.1007/s004200050216.
    1. Boogaard PJ, Vansittert NJ. Exposure to polycyclic aromatic hydrocarbons in petrochemical industries by measurement of urinary 1-hydroxypyrene. Occup. Environ. Med. 1994;51:250–258. doi: 10.1136/oem.51.4.250.
    1. Buchet JP, et al. Evaluation of exposure to polycyclic aromatic hydrocarbons in a coke production and a graphite electrode manufacturing plant: assessment of urinary excretion of 1-hydroxypyrene as a biological indicator of exposure. Br. J. Ind. Med. 1992;49:761–768.
    1. Jongeneelen F, et al. Ambient and biological monitoring of cokeoven workers: determinants of the internal dose of polycyclic aromatic hydrocarbons. Br. J. Ind. Med. 1990;47:454–461.
    1. Chobanian AV, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252. doi: 10.1161/01.HYP.0000107251.49515.c2.
    1. Ranjbar M, Rotondi MA, Ardern CI, Kuk JL. Urinary biomarkers of polycyclic aromatic hydrocarbons are associated with cardiometabolic health risk. PLoS One. 2015;10 doi: 10.1371/journal.pone.0137536.
    1. Zhang HM, et al. Effects of benzo[a]pyrene on autonomic nervous system of coke oven workers. J Occup Health. 2008;50:308–316. doi: 10.1539/joh.L7155.
    1. Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr. J. 2015;14 doi: 10.1186/1475-2891-14-6.
    1. Voight BF, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 2012;380:572–580. doi: 10.1016/S0140-6736(12)60312-2.
    1. Harchaoui KE, Visser ME, Kastelein JJ, Stroes ES, Dallinga-Thie GM. Triglycerides and cardiovascular risk. Curr. Cardiol. Rev. 2009;5:216–222. doi: 10.2174/157340309788970315.
    1. Wierzbicki AS. Homocysteine and cardiovascular disease: a review of the evidence. Diab. Vasc. Dis. Res. 2007;4:143–150. doi: 10.3132/dvdr.2007.033.
    1. Ruttmann E, et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation. 2005;112:2130–2137. doi: 10.1161/CIRCULATIONAHA.105.552547.
    1. Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: Clinical importance. Curr. Probl. Cardiol. 2004;29:439–493.
    1. Tofler GH, et al. Association between increased homocysteine levels and impaired fibrinolytic potential: Potential mechanism for cardiovascular risk. Thromb. Haemost. 2002;88:799–804.
    1. Howard BV, et al. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study. Arterioscler. Thromb. Vasc. Biol. 2000;20:830–835. doi: 10.1161/01.ATV.20.3.830.
    1. Farzan SF, Chen Y, Trachtman H, Trasande L. Urinary polycyclic aromatic hydrocarbons and measures of oxidative stress, inflammation and renal function in adolescents: NHANES 2003–2008. Environ. Res. 2016;144:149–157. doi: 10.1016/j.envres.2015.11.012.
    1. Alshaarawy O, Zhu M, Ducatman A, Conway B, Andrew ME. Polycyclic aromatic hydrocarbon biomarkers and serum markers of inflammation. A positive association that is more evident in men. Environ. Res. 2013;126:98–104. doi: 10.1016/j.envres.2013.07.006.
    1. Everett CJ, et al. Association of urinary polycyclic aromatic hydrocarbons and serum C-reactive protein. Environ. Res. 2010;110:79–82. doi: 10.1016/j.envres.2009.09.010.
    1. Yang B, et al. Exposure to polycyclic aromatic hydrocarbons, plasma cytokines, and heart rate variability. Sci. Rep. 2016;6 doi: 10.1038/srep19272.
    1. Svendsen KV, Svedahl SR, Lindh CH, Palmgren KB. Urinary 8-oxo-7, 8-dihydro-2′-deoxyguanosine concentrations after frying of bacon, a pilot study. Toxicol. Environ. Chem. 2017;99:525–534. doi: 10.1080/02772248.2016.1213262.
    1. Mazzachi BC, Peake MJ, Ehrhardt V. Reference range and method comparison studies for enzymatic and Jaffe creatinine assays in plasma and serum and early morning urine. Clin. Lab. 2000;46:53–55.
    1. Dhingra R, et al. Serum gamma-glutamyl transferase and risk of heart failure in the community. Arterioscler. Thromb. Vasc. Biol. 2010;30:1855–1860. doi: 10.1161/ATVBAHA.110.207340.
    1. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 2002;347:1557–1565. doi: 10.1056/NEJMoa021993.
    1. Di Angelantonio E, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302:1993–2000. doi: 10.1001/jama.2009.1619.

Source: PubMed

3
Sottoscrivi